TY - JOUR
T1 - Coronary artery calcifications on breast cancer radiotherapy planning CT scans and cardiovascular risk
T2 - What do patients want to know?
AU - Gal, Roxanne
AU - Gregorowitsch, Madelijn L.
AU - Emaus, Marleen J.
AU - Blezer, Erwin LA
AU - van der Leij, Femke
AU - van Velzen, Sanne GM
AU - van Tol-Geerdink, Julia J.
AU - Išgum, Ivana
AU - Verkooijen, Helena M.
N1 - Funding Information:
Prof. I Išgum reports grants from the Dutch Cancer Society (KWF), Pie Medical Imaging, the Dutch Technology Foundation , the Netherlands; Netherlands Organisation for Health Research and Development, the Netherlands , and the Dutch Heart Foundation, the Netherlands , and reported being cofounder of, and shareholder in Quantib-U BV. Prof. HM Verkooijen reports research grants from the Dutch Cancer Society ( KWF ) and Elekta AB. The other authors made no disclosures.
Funding Information:
This study was supported by the Dutch Cancer Society ( KWF ) [grant number UU 2015-7947 ].
Publisher Copyright:
© 2021
© 2021 Published by Elsevier B.V.
PY - 2021/12
Y1 - 2021/12
N2 - Background: Coronary artery calcifications (CAC) is a strong predictor of cardiovascular disease (CVD), which can be automatically quantified on routine breast radiotherapy planning computed tomography (CT) scans. Around 8% of patients have (very) high CAC scores and corresponding increased risks of CVD. Aim: This study explores whether, how, and under what conditions women with breast cancer want to be informed about their CAC-based CVD risk. Methods: A cross-sectional survey study was conducted in a random sample of UMBRELLA, a prospective breast cancer cohort. Participants (n = 79) filled out a questionnaire about their knowledge on the CVD risk following breast cancer, their interest in being informed about their CVD risk based on CAC score, and preferences on how they would want to receive this information. Results: Most participants (66%) were not aware that the presence of CAC indicates an increased CVD risk. Participants indicated that they were not or only slightly aware of the risk of treatment-induced cardiotoxicity (48%), and that the risk of cardiotoxicity was higher in patients with pre-existing CVD risk factors (82%). The vast majority (90%) indicated that they want to be informed about in increased CAC-based CVD risk. Conclusions: The majority of patients with breast cancer wants to be informed about their CAC-based CVD risk. With the majority of patients with breast cancer undergoing radiotherapy, and with low cost and automated options for accurate CAC measurement in planning CT scans, it is important to develop strategies to manage patients with an increased CAC-based risk of CVD.
AB - Background: Coronary artery calcifications (CAC) is a strong predictor of cardiovascular disease (CVD), which can be automatically quantified on routine breast radiotherapy planning computed tomography (CT) scans. Around 8% of patients have (very) high CAC scores and corresponding increased risks of CVD. Aim: This study explores whether, how, and under what conditions women with breast cancer want to be informed about their CAC-based CVD risk. Methods: A cross-sectional survey study was conducted in a random sample of UMBRELLA, a prospective breast cancer cohort. Participants (n = 79) filled out a questionnaire about their knowledge on the CVD risk following breast cancer, their interest in being informed about their CVD risk based on CAC score, and preferences on how they would want to receive this information. Results: Most participants (66%) were not aware that the presence of CAC indicates an increased CVD risk. Participants indicated that they were not or only slightly aware of the risk of treatment-induced cardiotoxicity (48%), and that the risk of cardiotoxicity was higher in patients with pre-existing CVD risk factors (82%). The vast majority (90%) indicated that they want to be informed about in increased CAC-based CVD risk. Conclusions: The majority of patients with breast cancer wants to be informed about their CAC-based CVD risk. With the majority of patients with breast cancer undergoing radiotherapy, and with low cost and automated options for accurate CAC measurement in planning CT scans, it is important to develop strategies to manage patients with an increased CAC-based risk of CVD.
KW - Breast cancer
KW - CAC
KW - Cardiovascular disease
KW - Coronary artery calcifications
KW - Patient preferences\
UR - http://www.scopus.com/inward/record.url?scp=85118870566&partnerID=8YFLogxK
U2 - 10.1016/j.ijcrp.2021.200113
DO - 10.1016/j.ijcrp.2021.200113
M3 - Article
C2 - 34816255
AN - SCOPUS:85118870566
VL - 11
JO - International Journal of Cardiology: Cardiovascular Risk and Prevention
JF - International Journal of Cardiology: Cardiovascular Risk and Prevention
M1 - 200113
ER -